XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Fair Value Measurements | 12 Months Ended
--- | ---
Dec. 31, 2021
Fair Value Measurements |
FAIR VALUE MEASUREMENTS | Note 10—Fair Value Measurements A reconciliation of the beginning and ending balances of the derivative liabilities is summarized below: ​
​ | ​ | ​ | ​
December 31, 2020 - Beginning of Period |  | ​ | ​
Warrant Liabilities - Public | ​ | $ | 21,390,000
Warrant Liabilities - Private | ​ |  | 11,449,330
Forward Purchase agreement | ​ |  | 7,692,950
December 31, 2020 | ​ | $ | 40,532,280
Change in fair value of warrant liabilities - Public | ​ |  | (7,314,000)
Change in fair value of warrant liabilities - Private | ​ |  | (3,914,930)
Change in fair value of forward purchase agreement | ​ |  | (4,872,950)
December 31, 2021 | ​ | $ | 24,430,400
​ The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and 2020, by level within the fair value hierarchy: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value Measured as of December 31, 2021
​ |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Cash and Investments held in Trust Account | ​ | $ | 414,111,439 | ​ | $ | — | ​ | $ | — | ​ | $ | 414,111,439
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Derivative liabilities - public warrants | ​ | ​ | 14,076,000 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 14,076,000
Derivative liabilities - private placement warrants | ​ | ​ | — | ​ | ​ | 7,534,400 | ​ | ​ | — | ​ | ​ | 7,534,400
Derivative liabilities - forward purchase agreement | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 2,820,000 | ​ | ​ | 2,820,000
Total liabilities | ​ | $ | 14,076,000 | ​ | $ | 7,534,400 | ​ | $ | 2,820,000 | ​ | $ | 24,430,400
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value Measured as of December 31, 2020
​ |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Cash and Investments held in Trust Account | ​ | $ | 414,020,525 | ​ | $ | — | ​ | $ | — | ​ | $ | 414,020,525
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Derivative liabilities - public warrants | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 21,390,000 | ​ | ​ | 21,390,000
Derivative liabilities - private placement warrants | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 11,449,330 | ​ | ​ | 11,449,330
Derivative liabilities - forward purchase agreement | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 7,692,950 | ​ | ​ | 7,692,950
Total liabilities | ​ | $ | — | ​ | $ | — | ​ | $ | 40,532,280 | ​ | $ | 40,532,280
​ Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement and the estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to a Level 2 fair value measurement, as a result of the Public Warrants being listed in an active market in February 2021. Prior to the Public Warrants being separately traded in an active market, the fair value of the Public Warrants issued in connection with the Public Offering and the Private Placement Warrants were measured using a binomial lattice model in a risk-neutral framework. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. Beginning in February 2021, the fair value of the Public Warrants are determined based on the listed price in an active market for such warrants and the fair value of the Private Placement Warrants is estimated to be approximately equal to that of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period. For the year ended December 31, 2021, the Company recognized a non-operating gain resulting from a decrease in the fair value of derivative liabilities of approximately $16.1 million, which is presented as change in fair value of derivative liabilities in the accompanying consolidated statements of operations. For the period from September 28, 2020 (inception) through December 31, 2020, the Company recognized a non-operating loss resulting from an increase in the fair value of derivative liabilities of approximately $10.7 million, which is presented as change in fair value of derivative liabilities in the accompanying consolidated statements of operations. The estimated fair value of the Private Placement Warrants, Public Warrants and Forward Purchase Agreement, as of December 31, 2021 and 2020 was determined using Level 3 inputs. The Company estimated the volatility of its ordinary share warrants based on implied volatility from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. The following table provides quantitative information regarding Level 3 fair value measurements inputs as of each measurement date: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of | ​ | As of |
​ | ​ | December 31, | ​ | December 31, |
​ |  | 2021 |  | 2022 |
Share price, used in warrant valuations | ​ | $ | 10.02 | ​ | ​ | n/a | ​
Unit price, used in forward valuation | ​ | $ | 10.54 | ​ | $ | 10.20 | ​
Exercise price, warrants | ​ | $ | 11.50 | ​ |  | n/a | ​
Exercise price, forward | ​ | $ | 10.00 | ​ | $ | 10.00 | ​
Term (in years), used in warrant valuations | ​ | ​ | 6.00 | ​ | ​ | n/a | ​
Term (in years), used in forward valuation | ​ | ​ | 0.96 | ​ | ​ | 0.25 | ​
Volatility | ​ |  | 21.00 | % |  | 15.5 | %
Risk-free interest rate, used in warrant valuations | ​ |  | 0.50 | % |  | n/a | ​
Risk-free interest rate, used in forward valuation | ​ |  | 0.10 | % |  | 1.28 | %
Expected dividends | ​ | ​ | n/a | ​ | ​ | n/a | ​
​ The change in the fair value of the derivative liabilities, classified as Level 3, for the periods ended December 31, 2021 and 2020 is summarized as follows: ​
​ | ​ | ​ | ​
Level 3 derivative liabilities at December 31, 2020 |  | $ | 40,532,280
Transfers from Level 3 | ​ | ​ | (32,839,330)
Change in fair value | ​ |  | (6,935,120)
Level 3 derivative liabilities at March 31, 2021 | ​ | ​ | 757,830
Change in fair value | ​ | ​ | (159,200)
Level 3 derivative liabilities at June 30, 2021 | ​ | ​ | 598,630
Change in fair value | ​ | ​ | 2,201,370
Level 3 derivative liabilities at September 30, 2021 | ​ | ​ | 2,800,000
Change in fair value | ​ | ​ | 20,000
Level 3 derivative liabilities at December 31, 2021 | ​ | $ | 2,820,000
​

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration